Zilver PTX Drug-Eluting Stent regulatory update

Cook Medical Inc. said Japan's Pharmaceuticals and Medical Devices Agency (PMDA) approved its Zilver PTX Drug-Eluting Stent to treat peripheral artery disease (PAD) in the superficial femoral artery (SFA). The company said the stent is the first approved in Japan for use in the SFA. Cook Medical is part of Cook Group. ...